Imara (IMRA) is expected to price its IPO on March 11. The biotech is looking to raise up to $80M to help it develop its pipeline of drug candidates for the treatment of sickle cell disease and thalassemia.
IPO lockup expirations
- SmileDirectClub (NASDAQ:SDC) and 10X Genomics (NASDAQ:TXG) on March 10,
- Cloudflare (NYSE:NET), SpringWorks Therapeutics (NASDAQ:SWTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and Alerus Financial (NASDAQ:ALRS) on March 11.
- Revolution Medicines (NASDAQ:RVMD), Duos (NASDAQ:DUOT), Huize (NASDAQ:HUIZ) and Yunhong (NASDAQ:ZGYHU)
